Combination treatment of gemcitabine and sorafenib exerts a synergistic inhibitory effect on non-small cell lung cancer in vitro and in vivo via the epithelial-to-mesenchymal transition process

Standard chemotherapy is commonly used in clinical practice for the treatment of non-small cell lung cancer (NSCLC). However, its therapeutic efficacy remains low. Combination therapy for cancer treatment has attracted attention in recent years. The present study aimed to investigate the antitumor e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shanshan, Wang, Rong, Zhang, Xuan, Wu, Feihua, Li, Shengnan, Yuan, Yongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291674/
https://www.ncbi.nlm.nih.gov/pubmed/32537024
http://dx.doi.org/10.3892/ol.2020.11536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291674/
https://www.ncbi.nlm.nih.gov/pubmed/32537024
http://dx.doi.org/10.3892/ol.2020.11536

Ejemplares similares